Literature DB >> 12766792

Homocysteine: a marker for cognitive performance? A longitudinal follow-up study.

C E Teunissen1, A Henk J Blom, M P J Van Boxtel, H Bosma, C de Bruijn, J Jolles, B A Wauters, H W M Steinbusch, J de Vente.   

Abstract

The present prospective study investigated whether elevated total serum homocysteine concentration is a risk factor for cognitive decline. The outcomes were compared to the possible relation between cognition and vitamin B12 or folic acid. Cognitive performance of 144 normal aging individuals (aged 30-80 years) was tested at baseline and after six years of follow-up. Domains of cognitive function addressed were cognitive speed (Letter-Digit Coding test), attention and information processing (Stroop test) and verbal learning and memory (Word Learning Test Total; Delayed Recall). Serum concentrations of homocysteine, folic acid and vitamin B12 were determined. Serum concentrations of homocysteine correlated negatively with cognitive performance on the Word Learning tests at baseline, independent of age, sex, education level or folic acid concentration. Homocysteine concentration at baseline correlated negatively with cognitive performance on the Stroop and Word Learning tests during the whole six-year follow-up period. The folic acid concentration correlated to the Delayed Recall test at baseline only and no correlations were observed for vitamin B12. Thus, while a relation between vitamin B12 or folic acid and cognition was almost absent, elevated homocysteine concentrations were associated with prolonged lower cognitive performance in this normal aging population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766792

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  18 in total

Review 1.  Thoughts on B-vitamins and dementia.

Authors:  Martha Clare Morris; Julie A Schneider; Christine C Tangney
Journal:  J Alzheimers Dis       Date:  2006-08       Impact factor: 4.472

Review 2.  Differential aging of the brain: patterns, cognitive correlates and modifiers.

Authors:  Naftali Raz; Karen M Rodrigue
Journal:  Neurosci Biobehav Rev       Date:  2006-08-17       Impact factor: 8.989

3.  Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease.

Authors:  Martha Clare Morris; Denis A Evans; Julie A Schneider; Christine C Tangney; Julia L Bienias; Neelum T Aggarwal
Journal:  J Alzheimers Dis       Date:  2006-08       Impact factor: 4.472

4.  Cognitive and social profiles in two patients with cobalamin C disease.

Authors:  M H Beauchamp; V Anderson; A Boneh
Journal:  J Inherit Metab Dis       Date:  2009-10-15       Impact factor: 4.982

5.  Total serum homocysteine levels do not identify cognitive dysfunction in multimorbid elderly patients.

Authors:  S Hengstermann; G Laemmler; A Hanemann; A Schweter; E Steinhagen-Thiessen; A Lun; R-J Schulz
Journal:  J Nutr Health Aging       Date:  2009-02       Impact factor: 4.075

6.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

7.  Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer's disease: the cache county memory, health and aging study.

Authors:  C Nelson; H J Wengreen; R G Munger; C D Corcoran
Journal:  J Nutr Health Aging       Date:  2009-12       Impact factor: 4.075

Review 8.  Homocysteine and cognitive function in elderly people.

Authors:  Angeles Garcia; Katherine Zanibbi
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

Review 9.  Vitamin B12 and health.

Authors:  Milly Ryan-Harshman; Walid Aldoori
Journal:  Can Fam Physician       Date:  2008-04       Impact factor: 3.275

10.  Total serum homocysteine levels do not identify cognitive dysfunction in multimorbid elderly patients.

Authors:  S Hengstermann; G Laemmler; A Hanemann; A Schweter; E Steinhagen-Thiessen; A Lun; R-J Schulz
Journal:  J Nutr Health Aging       Date:  2008 Jun-Jul       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.